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Abstract  
 
Nucleotide-Excision Repair (NER) factors, initially characterized as part of DNA repair, 
were also shown to belong to the transcriptional process in absence of genotoxic attack. 
However, their molecular function at the promoter of activated genes still remains obscure. 
Here we show that XPG and XPF endonucleases are required for establishing the CTCF-
dependent chromatin looping between the promoter and terminator of activated RARβ2. XPG 
promotes DNA break and demethylation around the promoter while XPF-ERCC1 acts at the 
terminator concomitantly to CTCF recruitment. Silencing or inhibiting XPG or XPF-ERCC1 
abolishes gene looping, DNA break formation and DNA demethylation.  
Our results contribute to the better understanding of transcriptional regulation by a timely 
orchestrated endonuclease activity of the NER factors XPG and XPF in the formation of 
the active chromatin hub that controls gene expression. This could also provide explanation 
for several clinical features of the patients with mutations in NER factors.  
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Introduction 
RNA synthesis is the result of a cascade of chronologically orchestrated events that 
requires several hundreds of proteins. Upon gene activation, a host of proteins including the 
RNA polymerase II (pol II), the general transcription factors (GTFs), coactivators, 
corepressors, and chromatin remodelers are assembled around the promoter and their 
enzymatic activities contribute to protein coding gene expression (Brivanlou and Darnell, 
2002; Kornberg, 2007). Among these proteins necessary to initiate RNA synthesis, are the 
Nucleotide-Excision-Repair (NER) factors (Le May et al., 2010; Schmitz et al., 2009). These 
factors were shown to be required for optimal chromatin remodeling including histones post-
translational modifications (PTMs) as well as DNA demethylation at the activated genes. 
These NER factors (XPC, CSB, TFIIH, XPA, XPG, XPF-ERCC1) were first characterized as 
part of the DNA repair machinery to eliminate lesions originated by exogenous or 
endogenous genotoxic attacks (For review, see (Nouspikel, 2009)). Mutations in the genes 
coding for NER factors have been associated with the human genetic disorders Xeroderma 
Pigmentosum (XP), Trichothiodystrophy (TTD), Cockayne Syndrome (CS), XFE progeroid 
syndrome and cerebro-oculo-facio-skeletal syndrome (COFS) (Jaspers et al., 2007; Kraemer 
et al., 2007; Niedernhofer et al., 2006).  
 In the present study, we investigated the implication of XPG and XPF-ERCC1 in the 
transactivation of nuclear receptor (NR)-target genes. We found that these two factors 
recruited at the promoter and terminator of activated genes, are necessary to promote 
chromatin looping and DNA demethylation, the two very crucial steps in transcription. 
 
Results 
 XPG and XPF are involved in DNA looping upon RARβ2 activation 
We first attempted to investigate the presence of the transcription and NER factors along 
the RARβ2 activated gene. Analysis of the promoter region (Pro) including two RAR-
responsive elements (RARE) and the TATA box as well as a region defined as the terminator 
(Ter) including the PolyA site, was performed using Chromatin Immunoprecipitation (ChIP) 
followed by quantitative PCR, at various times as indicated (Figure 1). Cells that either stably 
express targeted shRNA silencing XPG and ERCC1 (named SiXPF), XPA, or transitory 
express siRNA against CTCF as well as their respective corresponding controls (named 
SiCtrl1-3, see experimental procedure) were treated with all-trans retinoic acid (t-RA). 
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Silencing ERCC1 also silenced XPF (Figure 1, left panel, see also (Gaillard and Wood, 
2001)).   
In each silenced cell lines, we observed a significant defect in the RARβ2 mRNA 
expression compared to the SiCtrl1-3 cells (Figure 1, left panels). We noticed that as a 
function of the cell line and the set of experiments, RARβ2 mRNA synthesis peak either at 3 
or at 6 hours (h). We noticed RARβ2 mRNA synthesis peak either at 3 or at 6 hours as a 
function of respective cell lines and set of experiments. Therefore ChIPs were performed 
either at 0, 3 and 6 hours post-treatment.   
In SiCtrl1 cells at 6 hours post-treatment, we observed the concomitant recruitment of 
RAR, pol II and TFIIB together with the NER factors indicated by the presence of XPA, XPG 
and XPF (Figure 1, A2 and A6) at Pro paralleling RARβ2 mRNA synthesis (left panel). All of 
these proteins were also observed at Ter (panels A3 and A7). Such recruitment pattern was 
not detected at position 65 kb (-65kb) and 323 kb (+323kb), upstream and downstream to the 
transcription start site (TSS) respectively (panels A1, A5 and A4, A8). The recruitment 
pattern at Pro/Ter is different from the one found at exon 6 that lacks RAR as well as TFIIB 
(Figure S1). In SiCtrl2 and SiCtrl3, the transcription and the NER factors were similarly 
recruited at Pro and Ter, 3 hours post t-RA treatment (panels C1-C8 and F1-F8). Moreover, 
we noticed that the presence of the NER proteins was much less significant at the -65kb and 
+323kb regions (Figure 1). 
 Previous work has described the sequential arrival of the NER factors following the 
preinitiation complex (PIC) formation, with XPC, RPA and XPA preceding XPG and XPF-
ERCC1 (Le May et al., 2010). In SiXPG cells, XPA together with XPF and in SiXPF cells, 
XPA with XPG was detected at Pro although to a lower extent comparing with their 
respective SiCtrl1-2 (compare panels B2, B6, with panels A2, A6 and panels D2, D6 with 
panels C2 and C6). In SiXPG cells, transcription and NER factors are still recruited at Ter, 
but to a lower extent in comparison to SiCtrl1 (compare panels B3 and B7 with panels A3 and 
A7). However, in SiXPF cells, the co-recruitment of transcription machinery with XPA and 
XPG, obvious at Pro, was less significant at Ter (compare panels D2, D6 and D3, D7 with 
panels B2, B6 and B3, B7). In SiXPA cells, neither XPG nor XPF were detected at Pro and 
Ter (panels E6, E7 and panels C6, C7). Knowing that XPG stabilizes TFIIH architecture (Ito 
et al., 2007), it is not surprising that the absence of XPG might also partially disturb the 
formation of the entire transactivation complex, explaining the low recruitment of PIC and 
consequently a drop in RARβ2 mRNA synthesis. 
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We next found that in SiCtrl1-3, the CCCTC-binding factor (CTCF), a chromatin 
organizer (Phillips and Corces, 2009), was recruited at Pro and Ter upon t-RA induction 
(panels A6, A7, C6, C7, F6, F7). However CTCF was hardly detected on these regions in 
SiXPG, SiXPF and SiXPA cells (panels B6, B7, D6, D7 and E6, E7 respectively) when 
comparing with SiCtrl1-2.  
In SiCTCF cells, RARβ2 synthesis was significantly reduced compared to SiCtrl3 but not 
totally abolished  (Figure 1, left panel). The ChIP assay showed a concomitant detection of 
the NER factors with the transcriptional machinery at Pro but not at Ter (compare panels G2, 
G6 with panels F2 and F6 and panels G3, G7 with panels F3, F7). Although the presence of 
TFIIB as well as RAR was less pronounced than Pol II at Pro, it was interesting to notice their 
absence at Ter in SiCTCF (panel G3). Our data also suggest that the loop is not absolutely 
required for basal level of transcription, pol II being detected at exon 6 and at Ter in SiCTCF 
cells (Figure S1 and Figure 1G3; see also below).  
The correlated recruitment to distant regions (around 200 kilobases) along the RARβ2 
locus suggested the formation of gene looping. We thus performed quantitative Chromatin 
Conformation Capture assays (q3C) and analyzed interactions between several regions along 
the RARβ2 gene (Vernimmen et al., 2007). Digestion of crosslinked chromatin by HindIII 
resulted in restriction fragments equidistantly separated by 60kb and containing either -65 kb, 
Pro, Ter, +323 kb as well as an intronic region (M1) of the RARβ2 locus (Figure 2, upper 
scheme). Ter and M1 of RARβ2 gene were used as baits. In t-RA treated SiCtrl1 cells, we 
observed that Pro could specifically and significantly interact with Ter at 6 hours (Figure 2A), 
paralleling the RARβ2 mRNA synthesis (Figure 1, left panel) and the recruitment of the 
transcriptional apparatus (Figure 1, A2, A3, A6 and A7). Similar observations were made at 3 
hours in SiCtrl2-3 (data not shown). By contrast, in SiXPG, SiXPF and SiXPA cells as well 
as in SiCTCF, no spatial proximity between Ter and Pro was revealed. As controls, no 
specific interactions were observed between the intronic M1 bait and Pro as well as between 
all the other analyzed fragments upon t-RA treatment (Figure 2B). 
The above data indicate that the t-RA induction could initiate CTCF-related long-range 
interaction between Pro and Ter of RARβ2 gene that was abolished in absence of either XPG 
or XPF underlining the role of these NER factors in chromatin reorganization. 
  
 The catalytic activity of both XPG and XPF are required for gene looping 
 Consistent with the role of XPG and XPF-ERCC1 in NER (Gillet and Scharer, 2006; 
O'Donnovan et al., 1994; Sijbers et al., 1996), we were wondering about the requirement of 
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their endonuclease activity in chromatin looping upon transactivation. The SV40-
immortalized XP-G (XPCS1RO) and XP-F (XP2YO) fibroblasts that were derived from a 
XP/CS and XP patient respectively (Ellison et al., 1998; Yagi and Takebe, 1983) stably 
transfected either with XPG/WT, XPG/E791A or with XPF/WT, XPF/D676A (Figure S2A). 
XPG/E791A and XPF/676A mutations were found to abolish the catalytic activity of these 
two endonucleases and consequently their ability to eliminate DNA damages when added in 
an in vitro NER assay ((Lalle et al., 2002; Staresincic et al., 2009) and Figure S2B).  
RARβ2 mRNA synthesis was significantly inhibited in XPG/E791A and XPF/D676A cells 
as well as in the corresponding parental cells compared to the cells expressing either 
XPG/WT or XPF/WT respectively (Figure 3, panels A1, B1 and Figure S2, panels C and D). 
In XPG/WT and XPG/E791A cells, we observed a conserved recruitment of RAR, pol II, 
XPA, XPG and XPF both at Pro and Ter at 3 and 8 hours respectively (Figure 3, compare 
panels A2, A3 with panels A4, A5). In XPG/E791A cells, the optimal ChIP recruitment 
reflected the RARβ2 mRNA synthesis peak at 8 hours (panel A1). In XPF/D676A and 
XPF/WT cells, the recruitment patterns of transcription and NER factors were similar both at 
Pro and Ter (compare panels B4, B5 with panels B2, B3) contrary to what was observed at 
Ter in SiXPF cells (Figure 1, panels D3, D7). We also noticed that both XPG/E791A and 
XPF/D676A proteins were recruited with the other NER factors.  
However, in spite of the presence of both endonucleases in XPG/E791A and XPF/D676 
cells, q3C assay did not show any interaction between Pro and Ter while in both XPG/WT 
and XPF/WT cells, such interaction was observed at 3 and 6 hours upon t-RA induction 
respectively (Figure 3C and 3D). In XPG/WT and XPF/WT cells, CTCF was detected at both 
Pro and Ter concomitantly with gene looping (Figure 3, panels A2, A3 and B2, B3). In 
XPG/E791A or XPF/D676 cells, the inhibition of gene looping was coincident with the 
absence of CTCF (Figure 3, panels A4, A5 and B4, B5).  
These data indicate that the t-RA induction could initiate CTCF-dependent long-range 
interactions between Pro and Ter of RARβ2 gene, which was obliterated in the absence of 
catalytically active XPG or XPF-ERCC1. 
 
 XPG endonuclease induces DNA breaks and DNA demethylation at promoter region. 
Chromatin rearrangement involving DNA twists might require DNA breaks (Ju et al., 
2006). Using a Bio-ChIP assay which measures the incorporation of biotinylated dUTP within 
broken DNA, we observed a concomitant increase of DNA cleavage specifically both at Pro 
and Ter in all the five t-RA treated SiCtrl1, SiCtrl2, XPG/WT, XPF/WT and SiCtrl3 cells 
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(Figure 4, panel A1, B1, C1 and D1 respectively). In SiXPG and XPG/E791A cells, DNA 
breaks were not detected at Pro (Figure 4, panels A1, C1) whereas in SiXPF and XPF/D676 
cells, DNA cleavage could only be observed at Pro (panels B1 and C1). However we noticed 
that in XPG deficient cells, there was a slight incorporation of bio-UTP at Ter (panel A1). 
Several studies have documented some relationship between XPG and DNA demethylation 
upon transcription (Barreto et al., 2007; Jin et al., 2008; Schmitz et al., 2009). We thus 
investigated whether or not the endonuclease activity XPG and XPF was linked to DNA 
demethylation. Using an unmethylated DNA Immunoprecipitation (unMeDIP) approach, we 
measured the removal of the 5’-methyl-Cytosine (5mC) along the different regions of 
RARβ2. In all the five control cells, Pro and Ter were found unmethylated post t-RA 
treatment (Figure 4, panels A2, B2, C2 and D2). In SiXPG and XPG/E791A cells, Pro 
remained methylated while a DNA demethylation was observed at Ter when compared to 
their corresponding SiCtrl1 and XPG/WT cells (panels A2, C2). In SiXPF and XPF/D676 
cells, Pro but not Ter was unmethylated (panels B2 and C2). Using the Methylated DNA IP 
(MeDIP) approach, no significant decrease was observed in DNA methylation at both Pro and 
Ter in t-RA treated XPG/E791A and XPF/D767A cells (Figure S3), which was found to be 
consistent with the UnMEDIP (see above) assays and pyrosequencing data (see below, panel 
E). In XPG/WT and XPF/WT, we observed a weak but significant decrease of DNA 
methylation. Interestingly in SiXPA, neither DNA breaks nor DNA demethylation was 
detected at Pro and Ter (panels B1 and B2 respectively), likely due to the absence of XPG and 
XP (Figure 1, panels E6 and E7). 
Having demonstrated the connection between CTCF and the XPG and XPF endonucleases 
for chromatin looping, we then investigated whether the presence of CTCF is a prerequisite 
for DNA modifications. In SiCTCF, we repeatedly observed both DNA breaks and DNA 
demethylation at Pro but not at Ter when compared to SiCtrl3 (Figure 4, panels D1 and D2). 
These data strongly suggest a role for CTCF in the gene looping and Ter modification 
following DNA breaks and DNA demethylation of the Pro. 
To further localize the DNA modifications that occur during the formation of the 
transactivation complex, the promoter of RARβ2 was pyrosequenced. Pyrosequencing 
analysis of Bio-ChIP DNA samples from t-RA treated XPG/WT and XPF/WT cells indicated 
a high frequency of DNA breaks on both strands localized 300 nucleotides downstream the 
RARβ2 TSS (Figure 4E, red arrows); most of them were detected on the transcribed strand 
(TS). In XGP/E791A cells, the frequency of DNA cleavage strongly decreased and the 
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detected breaks were differently localized (panel E, light blue arrows). Interestingly, in 
XPF/D676A, the cleavage pattern observed around the RARβ2 promoter is similar (panel E, 
dark blue arrow), demonstrating that XPF endonuclease inhibition does not prevent Bio-UTP 
incorporation at Pro (see also panels B1 and C1).   
Genomic DNA was next bisulfite-converted and pyrosequenced to localize the 
demethylated 5mC at Pro in t-RA treated cells. Seventeen CpG dinucleotides, localized inside 
the proximal promoter and downstream the TSS, were analyzed (Figure 4, panel E). In 
XPG/WT, XPF/WT and XPF/D676A cells, CG1, CG3, CG15 and CG16 (closed dark blue 
circles) were significantly demethylated whereas only CG1 remained demethylated in 
XPG/E791A (Figure 4, panel E).  
The above data underline the role of XPG and XPF endonucleases in both the formation of 
DNA breaks and active DNA demethylation at Pro and Ter respectively. Our data also show 
that XPG dependent-DNA breaks and DNA demethylation at Pro precede the recruitment of 
CTCF. 
  
 Discussion 
Upon t-RA treatment, RAR nuclear receptor as well as the transcriptional machinery 
including mediator, GTFs, pol II are recruited at the promoter of RARβ2 gene. Then, NER 
factors where XPA precedes XPG and XPF are sequentially recruited (Le May et al., 2010). 
Indeed silencing XPA abolishes the recruitment of XPG and XPF at the RARβ2 promoter 
(Figure 1), all of them being necessary for optimal gene expression (Barreto et al., 2007; Le 
May et al., 2010; Schmitz et al., 2009). We also observed a long-range juxtaposition of the 
promoter and the terminator of the activated RARβ2 gene, a situation that constitutes an 
“active chromatin hub” as previously described for β-Globin, Igf2, BRCA1 loci and HIV-1 
provirus (de Laat and Grosveld, 2003; Spilianakis and Flavell, 2004) (Perkins et al., 2008; 
Tan-Wong et al., 2008). This higher order folding of chromatin, already reported for inter- 
and intra-chromosomal interactions between specific subsets of NR-bound transcription units 
(Hu et al., 2008; Nunez et al., 2008), provides additional control mechanisms for regulated 
gene expression (Deng and Blobel, 2010; Nunez et al., 2008).  
In the present study, we described how XPG and XPF might participate to optimal gene 
expression (see model Figure 5). We first show that the physical presence of both XPG and 
XPF is required to recruit the chromatin organizer CTCF and to participate in chromatin loop 
formation. Indeed, silencing either XPG or XPF is sufficient to inhibit the chromatin 
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rearrangement even in the presence of the other NER factors such as XPA (Figures 1 et 2). 
Moreover, mutations that affect the catalytic activity of XPG and XPF (XPG/E791A and 
XPF/D676A respectively) prevent CTCF recruitment, suggesting their functional involvement 
in the loop formation. In addition, we discovered that both chromatin looping and CTCF 
recruitment occur in parallel with the formation of DNA breaks. We especially observed that 
XPG/E791A mutation prevented DNA breaks formation at Pro (Figure 4). Since the XPF 
catalytic mutation does not affect those DNA modifications at Pro, it is tempting to suggest 
that upon t-RA transactivation and NER factors recruitment, XPG induces some DNA breaks 
at Pro independently of both the presence of CTCF and the status of XPF. Indeed, in SiCTCF, 
there are DNA breaks at Pro but not at Ter around which no NER factors were detected 
(Figure 4). Our results thus suggest that the action of XPF occurs once XPG has fulfilled its 
role at Pro and CTCF has been recruited.  
 Several studies have underlined the influence of DNA binding proteins such as activators 
and/or silencers in modifying chromatin environment in a DNA methylation dependent 
manner driving to specific loops formation and distinct gene expression as it was 
demonstrated for the imprinted Igf2/H19 (Murrell et al., 2004) and GATA-4 loci (Tiwari et al., 
2008).  
Using different approaches (UnMEDIP, MEDIP and pyrosequencing), we observed a 
relationship between the DNA demethylation at Pro and Ter and the presence of CTCF 
necessary for the loop formation of the RARβ2 activated gene. In particular we observed that 
demethylation at Pro is not sufficient to attract CTCF when Ter is not demethylated: XPG and 
XPF defects abolish DNA demethylation at Pro and Ter respectively and consequently CTCF 
recruitment (Figure 4). It thus is likely that following DNA breaks and DNA demethylation at 
Pro, CTCF recruitment is initiated with the assistance of XPF at Ter (Figure 5). 
 Mechanisms underlying the removal of methyl groups from genomic DNA are very 
controversial and have implicated DNA repair processes either through the deamination 
followed by excision of the 5mC or by direct removal of the methyl moiety from the base 
(Gehring et al., 2009; Ma et al., 2009). Our results do not allow the identification of the 
precise causal relationships between DNA demethylation and the effects of XPG and XPF 
endonucleases. They however support that XPG endonuclease and may be to a lower extent 
XPF, participate to the transcription process (Ito et al., 2007; Lee et al., 2002), either directly 
in the DNA demethylation itself and/or in the relaxation of chromatin conformation to drive 
gene activation (Barreto et al., 2007; Schmitz et al., 2009). Indeed, we found that the DNA 
breaks induced by XPG were located almost exclusively on the transcribed strand and nearby 
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the demethylated CG dinucleotides in the vicinity of RARβ2 TSS (Figure 4E). Whether or not 
DNA cuts are a prerequisite for DNA demethylation remains to be shown. However, the 
pattern of DNA cuts and demethylated 5mC is strongly disturbed when XPG and XPF 
endonucleases are inactivated.  
 Such localized roles of XPG at Pro and XPF at Ter as well as their cooperation in 
promoting loop formation and consequently optimal RARβ2 gene expression are reminiscent 
to the NER process in which XPF and XPG excise at the 3’ and 5’ of the DNA lesion, 
respectively in a cooperative manner (Tapias et al., 2004b)(Araujo et al., 2000; Staresincic et 
al., 2009). In NER, XPG mutations completely abolished the incision while XPF mutation 
still allow XPG cuts at the 5’ side of the DNA damage (Lalle et al., 2002).   
 As chromatin loop formation is abolished upon deficiency of kin28 the yeast counterpart 
of human cdk7 kinase (O'Sullivan et al., 2004), it would be legitimate to say about the 
possibility of some other inter-connecting links in this cascade of events followed by the 
action of XPA, XPG, XPF and CTCF.  In this later case, it is likely that defect in TFIIH that 
disturb either pol II (O'Sullivan et al., 2004) or NR phosphorylation (Compe et al., 2007) as 
well as mutation in the mediator that weaken interaction between activator and the basal 
transcription machineries (Hashimoto et al., 2011; Wang et al., 2005) indirectly disturb the 
proper recruitment and function of XPG/XPF endonucleases participating in DNA 
demethylation and DNA breaks formation and/or CTCF in chromatin loop formation.  
 The present study underlines the essential role of XPG, XPF and CTCF recruitment in the 
chromatin loop organization required for optimal expression of activated genes. Any kind of 
events that results in inaccurate transactivation complex formation as observed in XPA, XPG 
and XPF deficient cells, will result in altered gene expression that might at least partially 
explain the broad range of clinical features such as those observed within XP, TTD and 
XP/CS patients.  
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Experimental Procedure 
 
Cell Culture:  
HeLa Silencix cells (Tebu-Bio, provided by D. Biard) were used including SiCtrl (SiCtrl2, 
BD690), SiXPF and SiXPA cells. SiXPG cells and the corresponding control (SiCtrl1, SiLuc) 
were provided by R. Tanaka. SiCTCF and SiCtrl3 cells were obtained by respectively 
transfecting HeLa cells with SMART pool siRNA targeting CTCF or scrambled siRNA 
(Dharmacon) at a final concentration of 100nM. XPG/WT and XPG/E791A, as well as 
XPF/WT and XPF/D676A cells (gift from O. Scharer and W. Vermeulen) were obtained by 
the stable transfection of the corresponding wild type or mutated XPG and XPF constructs 
(Staresincic et al., 2009) in SV40-immortalized XP-G (XPCS1RO) and XP-F (XP2YO) 
(Ellison et al., 1998; Yagi and Takebe, 1983).   
All cells were cultured in appropriate medium. Cells were incubated with red phenol-free 
medium containing 10% charcoal treated Fetal Calf Serum (FCS) and 40µg/ml gentamycin. 
Cells were treated with 10µM all-trans-retinoic acid (t-RA) into the same medium. 
 
Antibodies:  
RNA pol II (7C2), RAR (9A6), XPA (1E9), TBP (3G3) and XPG (1B5) antibodies were 
from IGBMC antibody facilities. TFIIB (C-18), XPF (H-300) and Biotin (33) antibodies were 
obtained from Santa-Cruz Biotechnology, β-tubulin from Millipore and CTCF (ab70303) 
from Abcam. 
 
Reverse Transcription and Quantitative PCR 
Total RNA was isolated from several cell lines using a GenElute Mammalian Total RNA 
Miniprep kit (Sigma) and reverse transcribed with SuperScript II reverse transcriptase 
(Invitrogen). The quantitative PCR was done using the Lightcycler 480 (Roche). The primer 
sequences for RARβ2 and Glyceraldehyde 3-phosphate deshydrogenase (GAPDH) genes 
used in qPCR are available upon request. The RARβ2 mRNA expression represents the ratio 
between values obtained from treated and untreated cells normalized against the 
housekeeping GAPDH mRNA.  
 
Chromatin Immunoprecipitation:  
Cells were cross-linked at room temperature (RT) for 10 min with 1% formaldehyde. 
Chromatin was prepared and sonicated on ice 30 min using a Bioruptor (Diagenode) as 
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previously described (Le May et al., 2010). Samples were immunoprecipitated with 
antibodies at 4°C overnight and protein G-sepharose beads (Upstate) were added, incubated 4 
hours at 4°C and sequentially washed.  Protein-DNA complexes were eluted and DNA 
fragments were purified using QIAquick PCR purification kit (QIAGEN) and analyzed by 
quantitative PCR. 
 
Biotin-ChIP (Bio-ChIP):  
Cross-linked cells through a 1% formaldehyde treatment for 10 min at RT, were 
permeabilized with cytonin (Active Motif) 30 min at RT. After extensive washes with 
Phosphate Buffer Salt (PBS), Terminal deoxynucleotidyl Transferase (TdT) reaction was 
performed using Biotin-16-dUTP (Roche) and 60 units of recombinant enzyme rTdT 
(Promega). TdT reaction was stopped with specific stop buffer (Chemicon International) 15 
min at RT. After extensive washes with PBS, the resulted samples were sonicated on ice 20 
min (40 cycles: pulse 10s, pause 20s) using a Bioruptor (Diagenode) and immunoprecipitated 
using anti-Biotin antibodies and treated as described in the ChIP protocol. DNA fragments 
were purified using QIAquick PCR purification kit (QIAGEN) and analyzed by quantitative 
PCR using sets of primers,  
 
Quantitative Chromosome Conformation Capture (q3C): 
The quantitative chromosome conformation capture assay was performed as previously 
described (Vernimmen et al., 2007). Briefly, cells were cross-linked at RT for 10 min with 
2% formaldehyde. Cross-linked chromatin was digested in the appropriate restriction buffer 
by 400 units of enzyme HindIII. The restriction enzyme mixture was stopped, diluted in 
ligation buffer and incubated with the highly concentrated T4 DNA ligase (Roche) for 4 hours 
at 16°C. The cross-linking was heat-reversed and DNA fragments were purified. Undigested 
DNA or digested DNA without ligation step was used as negative controls. Moreover, we 
used as internal positive control the endogenous xpb locus that has been reported to adopt the 
same spatial conformation in different tissues (Vernimmen et al., 2007). All q3C results were 
normalized by data from xpb analysis (see Figure S2G), controlling for changes in nuclear 
size, chromatin density and cross-linking efficiency. Primers and probes were designed as 
follows: a universal sequence-specific Taqman probe and corresponding reverse primer on a 
fixed restriction fragment (Ter or M1) in combination with different forward primers specific 
of other restriction fragments (see upper panel Figure 2). Quantitative 3C templates (200ng) 
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were used for Taqman/PCR reaction using the universal PCR Master Mix and the Lightcycler 
480 from Roche.  
 
Unmethylated DNA Immunoprecipitation (unMeDIP):  
Genomic DNA was extracted using GenElute Mammalian Genomic DNA Mini-prep Kit 
(Sigma). Unmethylation of 5mC on the RARβ2 locus was measured by digesting 2µg 
genomic DNA with 10 units of MseI (Fermentas) and by using the UnMethylcollector kit 
(Active Motif). Unmethylated DNA Immunoprecipitation kit (UnMeDIP) is based on the 
affinity of the three zinc-coordinating CXXC domains, localized in chromatin-associated 
proteins such as DNA methyltransferase 1 (DNMT1) or mixed lineage leukemia (MLL), that 
specifically bind nonmethylated CpG sites. The resulted samples were selected using 
magnetic beads conjugated with CXXC domains, extensively washed and analyzed by 
quantitative PCR.  
 
Pyrosequencing 
Sequencing analyses. Pyrosequencing was performed on a Pyromark Q96 ID platform 
using the PSQ Gold SQA reagent kit (Qiagen). Briefly, 20µl amplified DNA products were 
mixed with 2µl Streptavidin Sepharose beads (Amersham Biosciences AB), 38µl binding 
buffer (10 mM Tris–HCl, pH 7.6, 2 M NaCl, 1 mM EDTA, and 0.1% Tween-20) and 20µL 
H2O, followed by shaking for 10 min. Then, the immobilized biotinylated PCR products—
Streptavidin Sepharose beads complex was captured using the Qiagen Pyromark Q96 Work 
Station. Single strand DNA purification was achieved by sequential washes with 75% ethanol, 
0.2 M NaOH and washing buffer (10 mM Tris-acetate, pH7.6). The unbiotinylated strand was 
dissociated and discarded. The immobilized single biotinylated strands were released to a 96-
well microtiter plate, which was pre-added with 38µl annealing buffer and 2µl complementary 
sequencing primer. The plate was incubated at 80°C for 2 min, followed by slow cooling to 
room temperature. The processed mixture was loaded onto the PyroMark ID system equipped 
with PyroMark ID software. The resulting pyrograms and associated sequences were 
generated and analyzed automatically using PSQ 96 SQA software (Qiagen). 
Methylation analyses. Pyrosequencing was performed using a PyroMark Q96 ID 
Pyrosequencing instrument (Qiagen). Pyrosequencing assays were designed using 
MethPrimer (http://www.urogene.org/methprimer/index1.html). 200ng of genomic DNA was 
treated with EZ DNA Methylation-Gold Kit (Zymo Research Corporation) and amplified 
using 1.25 U Platinum Taq DNA Polymerase (Invitrogen) and 1µM each forward and reverse 
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primers in a 50µL reaction volume with 0.2mM dNTP and 1.5mM MgCl2. PCR conditions 
were 94°C for 3 min, then 40 cycles of 94°C for 30 sec, Tm for 30 sec and 72°C for 30 sec, 
followed by a 9 min extension at 72°C. Biotin-labeled single stranded amplicons were 
isolated using the Qiagen Pyromark Q96 Work Station and underwent pyrosequencing  with 
0.5 µM primer. The percent methylation for each of the CpGs within the target sequence was 
calculated using PyroQ cpG Software (Qiagen). All methylation analyses were performed in 
duplicate. 
 
All the sets of primers and probes targeting different regions of RARβ2 gene and used for 
the qPCR analysis are available upon request.  
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Figures Legends: 
 
Figure 1: XPG, XPF and CTCF are necessary for concomitant recruitment of 
transcription machinery at promoter and terminator upon RARβ2 induction.  
Schematic representation of the RARβ2 gene with the indicated amplicons designed at the 
-65kb, Pro, Ter and +323kb regions (Upper panel).  
Overtime relative RARβ2 mRNA expression monitored by qPCR from t-RA treated 
SiXPG, SiXPF, SiXPA and siCTCF HeLa cells, and the corresponding SiCtrl 1, SiCtrl 2 and 
SiCtrl 3 control cells (left panels). Error bars represent the standard deviation of three 
independent experiments. Western-blotting analysis of XPG, XPF, XPA CTCF and TBP were 
performed from chromatin extracts of SiXPG, SiXPF, SiXPA and SiCTCF HeLa cells and 
their corresponding controls (left panels). TBP is used as a positive nuclear marker. 
ChIP monitoring the t-RA-dependent occupancy of RAR, pol II, TFIIB (A1-4, B1-4, C1-4, 
D1-4, E1-4, F1-4, G1-4), XPA, XPG, XPF and CTCF (A5-8, B5-8, C5-8, D5-8, E5-8, F5-8, 
G5-8) on RARβ2 locus from SiXPG (B1-8), SiXPF (D1-8), SiXPA (E1-8), SiCTCF (G1-8) 
and the corresponding controls (SiCtrl1, SiCtrl 2, SiCtrl3) chromatin extracts at 0, 3 and 6 
hours upon t-RA induction as indicated. A1-4, A5-8 --- G5-G8 are aligned under the 
corresponding region of the RARβ2 gene being probed. Each series of ChIP is representative 
of at least two independent experiments and values are expressed as % of the input.  
 
Figure 2: XPG and XPF is involved in CTCF-induced RARβ2 gene looping.  
Schematic representation of the quantitative Chromatin Conformation Capture (q3C) for 
the analysis of the intra-chromosomal interactions along the RARβ2 locus (upper panel). Two 
probes were designed at Ter (grey square) and M1 (green square) of RARβ2 gene. These 
probes were used to investigate the associations between the different elements including 
upstream (-65kb, Pro), intronic (M1, M2) and downstream (Ter, +257kb, +323kb, +385kb) 
regions as indicated by the black (Ter probe) and red (M1 probe) arrows.  
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q3C assays were performed using crosslinked and HindIII-digested chromatin from 
SiCtrl1, SiXPG, SiXPA, SiXPF and siCTCF HeLa cells at 0, 3 and 6 hours post t-RA 
treatment (10 µM). The bar chart (Y axis) shows the enrichment of PCR product (%) 
normalized to the enrichment within the human xpb gene (=100%), as illustrated in Figure 
S2G. Each PCR was performed at least three times and averaged as indicated by standard 
deviation. Signals were normalized to the total amount of DNA used, estimated with an 
amplicon located within a HindIII fragment in RARβ2 gene (see experimental procedure). 
 
Figure 3: Endonuclease activity of XPG and XPF are required for gene looping. 
Relative RARβ2 mRNA expression monitored by quantitative PCR from XPG/WT (A1), 
XPG/E791A (A1), XPF/WT (B1), XPF/D676A (B1) cells at 0, 1, 3, 6, 8, 10 hours post t-RA 
treatment. Error bars represent the standard deviation of three independent experiments.  
ChIP monitoring the t-RA-dependent occupancy of RAR, pol II, XPA, XPG, XPF and 
CTCF at Pro and Ter regions of RARβ2 gene from XPG/WT (A2-3), XPG/E791A (A4-5) and 
XPF/WT (B2-3), XPF/D676A (B4-5) chromatin extracts as indicated. Each series of ChIP is 
representative of two independent experiments.  
Intra-chromosomal interactions between Ter and upstream/downstream elements of 
RARβ2 gene: Q3C assays were performed using crosslinked, HindIII-digested chromatin 
from t-Ra treated XPG/WT or XPG/E791A (C) and XPF/WT or XPF/D676A (D) fibroblasts 
at 0, 3 and 6 hours. These independent graphs represent a measure of the association between 
the upstream -65kb, Pro, the intronic M1 and M2 elements, the downstream +257 kb, +323kb 
and +385kb regions to either the terminal region (Ter Probe) or the intronic region (M1 
Probe, see Figure S2, panels E and F) as negative control. Each PCR was performed at least 
three times and averaged as indicated by standard deviation. Signals were normalized to the 
total amount of DNA used, estimated with an amplicon located within a HindIII fragment in 
RARβ2 gene. 
 
Figure 4:  XPG and XPF are required for DNA breaks and DNA demethylation at 
Pro and Ter respectively. 
Detection of DNA break at -65kb, Pro, Ter and +323kb of the RARβ2 locus from SiCtrl1, 
SiXPG (A1), SiCtrl2, SiXPA, SiXPF (B1), XPG/WT, XPG/E791A (C1) and XPF/WT, 
XPF/D676A (D1) t-RA treated cells. DNA break are detected through firstly the 
incorporation of Biotin-dUTP via a Terminal deoxynucleotidyl Transferase (TdT) reaction 
and secondly a ChIP approach. DNA fragments containing DNA breaks are immunoselected 
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by biotin antibodies and analyzed by qPCR. Each serie of Bio-ChIP is representative of three 
independent experiments and values are expressed as % of the input.  
Analysis of the unmethylation of DNA (UnMedIP) at -65kb, Pro, Ter and +323kb of the 
RARβ2 locus from SiCtrl1, SiXPG (A2), SiCtrl2, SiXPA, SiXPF (B2), XPG/WT, 
XPG/E791A (C2) and XPF/WT, XPF/D676A (D2) t-RA treated cells. UnMedIP was 
performed using the UnMethylCollector kit (Active Motif). MseI digested genomic DNA was 
selected using magnetic beads conjugated with CXXC domains and the resulted samples 
containing unmethylated DNA were analyzed by qPCR. Each serie of UnMedIP is 
representative of two independent experiments and values are expressed as % of the input.  
(E) Schematic representation of the methylated (open circle) or unmethylated (close circle) 
CpG dinucleotides (in red) and DNA break (close triangle) along the RARβ2 promoter for 
WT (red), XPG/E791A (light blue) and XPF/D676A (dark blue) cells. DNA break was 
localized at Pro by pyrosequencing the samples generated by Bio-ChIP. The methylated status 
of CpG dinucleotides at Pro was measured using bisulfite converted genomic DNA from 
XPG/WT, XPG/E791A and XPF/WT, XPF/D676A fibroblasts and pyrosequencing. 
 
Figure 5: A role for XPG and XPF in the CTCF-dependent gene looping for optimal 
gene expression. 
Upon the ligand induction, Nuclear Receptor (NR) targets its responsive element (RE). 
The transactivation complex is then formed at the promoter (PRO) including the arrival of 
GTFs (IIA, IIB, IIE, IIF, IIH) and pol II. After the formation of the PIC, NER factors (XPA, 
XPG and XPF/ERCC1) are sequentially recruited. XPG (red arrow) initiates DNA break 
(doted DNA) and demethylation (meC--C) at PRO, thus favouring the CTCF recruitment and 
gene looping between PRO and the terminator TER; Concomitantly, XPF (red arrow) induces 
DNA break (doted DNA) and DNA demethylation at TER.  
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SUPPLEMENTAL INFORMATION  
 
Supplemental figures 
 
Figure S1. Presence of NER factors actors at exon 6 of RARb2: 
ChIP monitoring the occupancy of RAR, pol II, TFIIB, XPA, XPG, XPF and CTCF at 
RARβ2 exon 6 from SiXPG (B), SiXPA (D), SiXPF (E), SiCTCF (G) and the corresponding 
controls SiCtrl1 (A), SiCtrl 2 (C), SiCtrl3 (F) chromatin extracts at 0, 3 and 6 hours post t-RA 
treatment as indicated. Each series of ChIP is representative of two independent experiments 
and values are expressed as % of the input.  
 
Figure S2. Endonuclease activity of XPG and XPF; negative control for q3C for XPG 
and XPF cells. 
(A) Steady-state level of XPG, XPF and b-tubulin in XP-G, XPG/WT, XPG/E791A (left 
panel) and XP-F, XPF/WT, XPF/D676A (right panel) cells. Western-blotting analysis was 
performed from chromatin extracts of the different cells. Detection of XPG, XPF, and b-
tubulin (as a positive marker) was tested with appropriate antibodies. 
(B) In vitro NER assay (Lalle et al., 2002; Tapias et al., 2004a ) using nuclear extracts 
(NE) from XPF/WT (lanes 1 to 4) and XPF/D676A (lanes 5 to 8) cells expressing either 
XPF/WT or XPF/D676A and supplemented by either recombinant XPF or XPF/WT as 
indicated, (lanes 4 and 8). As a control, the NER assay was realized either with HeLa nuclear 
extracts (NE) or recombinant XPF alone (lanes 9 and 10 respectively).  
Relative RARβ2 mRNA expression monitored by quantitative PCR from the parental XP-
G, XPG/WT or XPG/E791A (panel C) and the parental XP-F, XPF/WT or XPF/D676A 
(panel D) cells treated overtime (0, 1, 3, 6, 8, 10 hours) with t-RA (10 µM). 
Intra-chromosomal interactions between internal M1 regions of RARβ2 gene and 
upstream/downstream elements as indicated figure 3 from t-RA treated XPG/WT or 
XPG/E791A (panel E) and XPF/WT or XPF/D676A cells (panel F).  
(G) xpb level was monitored in XPG/WT, XPG/E791A, XPF/WT and XPF/D676A cells 
untreated (T0) or treated (T(h)) with t-RA (10 µM) by PCR.  
 
Figure S3. DNA methylation measured by MedIP in XPG/WT, XPG/E791A, 
XPF/WT and XPF/D676A fibroblasts.  
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Analysis of the DNA methylation (MedIP) at Pro and Ter from untreated (T0) or t-RA 
treated (T(h)) XPG/WT, XPG/E791A, XPF/WT, XPF/D676A chromatin extracts. MedIP was 
performed using the MethylCollector ultra kit (Active Motif). MseI digested genomic DNA 
was selected using His-tagged MBD2b/MDB3L1 protein complexes and nickel-coated 
magnetic beads. The resulted samples containing methylated DNA were analyzed by qPCR. 
Each serie of MedIP is representative of two independent experiments and values are 
expressed as % of the input.  
 
Figure S4. CpG methylation in XPG and XPF cells. 
(A) Specific primers sequences using for pyrosequencing from XPG/WT and XPG/E791 
and XPF/WT and XPF/D676A cells.  
(B) Histograms show the percentage of methylation of the different cytosine along the 
promoter for XPG/WT or XPF/WT (grey bar) and XPG/E791 XPF/D676A (black bar) cells 
lines. Each serie of pyrosequencing is representative of two independent experiments.  
 
Methods 
 
In vitro NER assay: 
Reconstituted dual incision reactions (Riedl et al., 2003) were carried out in a buffer 
containing 50 mM HEPES–KOH pH 7.6, 20 mM Tris–HCl pH 7.6, 50 mM KCl, 2.5 mM 
MgCl2, 0.5 mM DTT, 0.5 mM EDTA, 10% glycerol, 0.02% NP40 and 2 mM ATP. NER 
factors were purified as described (Araujo et al., 2000) and used in saturating amounts: XPC-
HR23B (10 ng), TFIIH HAP (50 ng) , XPA (30 ng), RPA (200 ng), XPG (50 ng) and XPF-
ERCC1 (10 ng) per reaction. The NER factors were incubated with 40 fmols of either free or 
immobilized damaged DNA substrate, for 40 min at 30°C in the presence of ATP. Reactions 
were stopped by boiling for 5 min after addition of 9 ng 32 nt oligonucleotide complementary 
to the excised DNA fragment with a 5'-extension of four extra G residues. After annealing the 
oligonucleotide to the excised DNA fragment, excision products were radiolabelled by 
extension with 0.15 U of Sequenase version 2.0 polymerase (U.S.B.) and 2 Ci of [-32P]dCTP 
(3000 Ci/mmol). Labelled excision products were separated on a denaturing 14% 
polyacrylamide gel and visualized by autoradiography. Dual incision reactions with HeLa NE 
were performed in the presence of 15 M wortmannin, 60 M aphidicolin and 2% DMSO; 
reactions were pre-incubated for 10 min at 30°C before DNA substrate addition and further 
incubated at 30°C for 40 min or indicated times. 
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Methylated DNA Immunoprecipitation (MeDIP):  
Genomic DNA was extracted using GenElute Mammalian Genomic DNA Mini-prep Kit 
(Sigma). Methylation status of CpG dinucleotides localized on the RARβ2 locus was 
investigated by digesting 2µg genomic DNA with 10 units of MseI (Fermentas) and was 
performed using the Methylcollector ultra kit as described by Active Motif. Methylated DNA 
Immunoprecipitation kit (MeDIP) is based on the high affinity of the Methyl-CpG binding 
proteins (MBD) MBD2b and its binding partner MBD3L1 for the methylated DNA 
fragments. The resulted samples were selected using His-tagged MBD2b/MDB3L1 protein 
complexes and nickel-coated magnetic beads, extensively washed and analyzed by 
quantitative PCR using sets of primers, available upon request, targeting different regions of 
RARβ2 gene. 
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